Drug Guide
Ampicillin Sodium; Sulbactam Sodium
Classification
Therapeutic: Antibacterial, antibiotic
Pharmacological: Penicillin antibiotic combined with beta-lactamase inhibitor
FDA Approved Indications
- Infections caused by susceptible bacteria, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, gynecological infections, intra-abdominal infections
Mechanism of Action
Ampicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis. Sulbactam inhibits beta-lactamase enzymes produced by bacteria, protecting ampicillin from degradation, thereby extending its spectrum of activity.
Dosage and Administration
Adult: 1-3 g every 8-12 hours IV or IM, doses may vary based on severity and site of infection
Pediatric: Typically 50-100 mg/kg/day divided every 8-12 hours IV or IM; dosing adjustments needed for renal impairment
Geriatric: Adjust dose based on renal function; no specific age-related contraindications but increased caution due to renal function decline
Renal Impairment: Dose adjustment required; generally, dosage interval increased or reduced depending on renal function
Hepatic Impairment: No specific adjustment required; monitor for hepatic effects if prolonged therapy
Pharmacokinetics
Absorption: IV and IM administration—rapid and complete
Distribution: Widely distributed, including cerebrospinal fluid (CSF) in inflamed meninges
Metabolism: Minimal hepatic metabolism
Excretion: Primarily renal (glomerular filtration and tubular secretion)
Half Life: Approximately 1 hour
Contraindications
- History of allergic reactions to penicillins or beta-lactam antibiotics
Precautions
- History of allergy to cephalosporins, renal impairment, monitor for superinfections, pregnancy and lactation considerations
Adverse Reactions - Common
- Allergic reactions (rash, urticaria) (Uncommon)
- Diarrhea (Common)
- Nausea, vomiting (Occasional)
Adverse Reactions - Serious
- Anaphylaxis (Rare)
- Clostridioides difficile-associated diarrhea (Uncommon)
- Hematologic reactions (eosinophilia, neutropenia, thrombocytopenia) (Rare)
Drug-Drug Interactions
- Aminoglycosides (synergistic effect), Warfarin (altered INR), Probenecid (increases ampicillin levels)
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for signs of allergic reactions, assess renal function, monitor for superinfections
Diagnoses:
- Risk of allergic reaction
- Risk for secondary infections
Implementation: Administer IV/IM doses as prescribed, monitor renal function, ensure adequate hydration to prevent renal precipitation of drug
Evaluation: Evaluate infection resolution, monitor for adverse effects
Patient/Family Teaching
- Report any allergic reactions immediately
- Complete full course of therapy even if symptomatic improves
- Maintain adequate hydration during therapy
Special Considerations
Black Box Warnings: N/A
Genetic Factors: None established
Lab Test Interference: May cause false positive reaction in Coombs test and certain urine glucose tests
Overdose Management
Signs/Symptoms: Gastrointestinal symptoms, seizures (rare), neurotoxicity in renal failure
Treatment: Supportive care, observe, and consider dialysis in severe cases
Storage and Handling
Storage: Store at room temperature (15-30°C), protect from light and moisture
Stability: Stable until the expiration date on the package